Mycoses

Papers
(The H4-Index of Mycoses is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
198
Issue Information156
Immunohistochemical analysis of chronic and recurrent dermatophytosis128
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis103
81
Intra‐ and inter‐laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing80
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis70
Issue Information52
Issue Information45
Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case‐control study44
Issue Information43
Comparison of four diagnostic criteria for invasive pulmonary aspergillosis—A diagnostic accuracy study in critically ill patients42
Physicians' knowledge of invasive fungal disease in China40
38
37
Seasonality of sporotrichosis in Brazil: A modelled analysis of the epidemic in São Paulo, 2011–202037
Author Index36
In vitro activities of 8 antifungal drugs against 126 clinical and environmental Exophiala isolates35
Issue Information34
Multi‐state evaluation of Candida infections in burn patients33
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study32
Issue Information29
Molecular Epidemiology and Antifungal Susceptibility Profile of Candidozyma Isolates From Argentina29
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients29
Review Article White Piedra: Review of 131 cases27
A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates25
Clinical characteristics and outcomes of invasive and non‐invasive fusariosis in South Korea25
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study25
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting25
Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification25
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study25
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist25
Endemic mycoses: Expansion of traditional geographic ranges and pitfalls in management25
0.070990085601807